Cargando…
Investigation of the performance of serological assays used for Lyme disease testing in Australia
Spirochaetes of the Borrelia burgdorferi sensu lato complex, which includes those that cause Lyme disease, have not been identified in Australia. Nevertheless, Australian patients exist, some of whom have not left the country, who have symptoms consistent with so-called “chronic Lyme disease”. Blood...
Autores principales: | Best, Susan J., Tschaepe, Marlene I., Wilson, Kim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488061/ https://www.ncbi.nlm.nih.gov/pubmed/31034492 http://dx.doi.org/10.1371/journal.pone.0214402 |
Ejemplares similares
-
Development of a sensitive PCR-dot blot assay to supplement serological tests for diagnosing Lyme disease
por: Shah, J. S., et al.
Publicado: (2017) -
Lyme disease in Minnesota: epidemiologic and serologic findings.
por: Osterholm, M. T., et al.
Publicado: (1984) -
Lyme disease in Australia--still to be proven!
por: Russell, R C
Publicado: (1995) -
Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.
por: Craven, R B, et al.
Publicado: (1996) -
Serological evidence of possible Borrelia afzelii lyme disease in Greece
por: Karageorgou, I., et al.
Publicado: (2022)